What is the recommended treatment and dosage of racecadotril (acetorphan) for a 21-year-old male with watery diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Racecadotril for Acute Watery Diarrhea in Adults

For a 21-year-old male with watery diarrhea, racecadotril 100 mg three times daily is an effective antisecretory agent that should be used as an adjunct to oral rehydration therapy, particularly when loperamide is contraindicated or not tolerated. 1

Mechanism and Clinical Role

  • Racecadotril is an enkephalinase inhibitor that reduces pathologic intestinal water and electrolyte secretion without affecting gastrointestinal motility or transit time 2, 3
  • The drug works by inhibiting neutral endopeptidase, thereby increasing enkephalin exposure, which exhibits antisecretory effects in the small intestine 2, 3
  • ESMO guidelines specifically recommend racecadotril as first-line symptomatic treatment for Grade 1 immunotherapy-induced diarrhea, alongside loperamide 1

Dosing for Adults

The standard adult dose is 100 mg orally three times daily 4

  • This dosing regimen has been validated in multinational trials involving 945 patients with acute watery diarrhea 4
  • Treatment should continue until diarrhea resolves, typically within 55 hours based on clinical trial data 4

Efficacy Evidence

  • In direct comparative studies with loperamide, racecadotril demonstrated equivalent efficacy in resolving diarrhea (median duration 55 hours for both agents) with 92% treatment success rates 4
  • Racecadotril produced significantly greater reduction in abdominal pain (P=0.024) and distension (P=0.03) compared to loperamide 4
  • The duration of abdominal distension was markedly shorter with racecadotril (5.4 hours versus 24.4 hours with loperamide, P=0.0001) 4

Safety Profile and Advantages

  • Racecadotril causes significantly less rebound constipation than loperamide (16% versus 25%, P=0.001) 4
  • Overall adverse events were significantly lower with racecadotril (14.2%) compared to loperamide (23.9%, P=0.001) 4
  • No serious adverse events have been reported with racecadotril use 3
  • The drug does not cross the blood-brain barrier, avoiding central nervous system effects 2

Treatment Algorithm

Step 1: Ensure adequate hydration first

  • Initiate oral rehydration solution as primary therapy for mild to moderate dehydration 1
  • Use intravenous fluids (lactated Ringer's or normal saline) only for severe dehydration, shock, or altered mental status 1

Step 2: Screen for contraindications

  • Check for fever >38.5°C, bloody stools, or severe abdominal pain—these require different management and antimotility agents should be avoided 5
  • Assess for suspected inflammatory diarrhea or toxic megacolon risk 1

Step 3: Initiate racecadotril

  • Administer 100 mg orally three times daily once hydration is addressed 4
  • Continue until diarrhea resolves 4

Step 4: Consider antimicrobial therapy if indicated

  • For traveler's diarrhea with severe symptoms, add azithromycin 1000 mg single dose or 500 mg for 3 days 5
  • Empiric antibiotics are NOT recommended for most acute watery diarrhea without recent international travel 1

Critical Pitfalls to Avoid

  • Never use racecadotril or any antimotility agent before establishing adequate hydration status 5
  • Avoid in patients with bloody diarrhea, high fever, or suspected Shiga toxin-producing E. coli infection 1
  • Do not use as monotherapy—racecadotril is an adjunct to oral rehydration, not a replacement 1, 3
  • While IDSA guidelines note racecadotril reduces stool volume, they also state it is not available in North America, limiting its use in the United States 1

Comparative Context

  • Racecadotril is particularly useful when loperamide causes problematic constipation or when patients experience significant abdominal cramping 4
  • Unlike loperamide, racecadotril does not slow intestinal transit, theoretically reducing the risk of bacterial overgrowth or toxin retention 2
  • The drug has proven efficacy across diverse populations in developing countries with various causes of acute watery diarrhea 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Drugs in Focus: The Use of Racecadotril in Paediatric Gastrointestinal Disease.

Journal of pediatric gastroenterology and nutrition, 2020

Guideline

Alternative Anti-Diarrheal Medications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.